Hantz Financial Services’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21K Buy
1,406
+300
+27% +$2.9K ﹤0.01% 1930
2026
Q1
$8K Sell
1,106
-117
-10% -$1.23K ﹤0.01% 2095
2025
Q4
$14K Buy
1,223
+367
+43% +$3.96K ﹤0.01% 1906
2025
Q3
$7K Buy
+856
New +$6K ﹤0.01% 1939
2025
Q2
Sell
-309
Closed -$3K 2261
2025
Q1
$3K Buy
+309
New +$3.86K ﹤0.01% 1302

Other funds holding NEO

Hantz Financial Services's NEO Position: Q2 2026 in Review

Hantz Financial Services increased its NeoGenomics (NEO) stake by 27% in Q2 2026, buying an estimated $2.9K and bringing the position to 1,406 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #1930.

Hantz Financial Services first reported a position in NEO in Q1 2025 and has held it in 5 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Hantz Financial Services held 1,406 shares of NeoGenomics worth $21K as of Q2 2026.
  • Hantz Financial Services bought 300 NeoGenomics shares in Q2 2026, an estimated $2.9K.
  • NeoGenomics made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #1930 holding.
  • Hantz Financial Services first reported a position in NeoGenomics in Q1 2025 and has held it in 5 quarters since.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.